Entecavir or tenofovir monotherapy prevents HBV recurrence in liver transplant recipients: A 5-year follow-up study after hepatitis B immunoglobulin withdrawal.
暂无分享，去创建一个
N. Heaton | P. Lampertico | M. Heneghan | K. Agarwal | I. Carey | Gavin Whitehouse | M. Manini | M. Bruce | A. Suddle | T. Y. Lim | Matteo Passerini | A. Considine